Transforming dementia diagnostics and care: developing a novel, cost‐effective technology to facilitate widespread and cost‐effective clinical implementation of neurofilament light and other biomarkers

A cost-effective, high-throughput PLA platform for NfL and other biomarkers, seamlessly integrated into routine clinical pathology workflows, could revolutionise diagnostics and research. This approach has the potential to improve access to timely and accurate diagnosis globally, leading to better outcomes for patients, families, and healthcare systems.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_101930
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transforming dementia diagnostics and care: developing a novel, cost‐effective technology to facilitate widespread and cost‐effective clinical implementation of neurofilament light and other biomarkers

Christa Dang, Dhamidhu Eratne, Dennis Velakoulis, Kaj Blennow et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Transforming dementia diagnostics and care: developing a novel, cost‐effective technology to facilitate widespread and cost‐effective clinical implementation of neurofilament light and other biomarkers

Christa Dang, Dhamidhu Eratne, Dennis Velakoulis, Kaj Blennow, Matthew J.Y. Kang, Henrik Zetterberg, Jeff Smith, Kruti Patel, Cherie Chiang, The MiND Study Group
article en

Abstract

A cost-effective, high-throughput PLA platform for NfL and other biomarkers, seamlessly integrated into routine clinical pathology workflows, could revolutionise diagnostics and research. This approach has the potential to improve access to timely and accurate diagnosis globally, leading to better outcomes for patients, families, and healthcare systems.

Alzheimer s & DementiaVol. 21(S2)
The Royal Melbourne Hospital (AU), The University of Melbourne (AU), Walter and Eliza Hall Institute of Medical Research (AU), Hong Kong Science and Technology Parks Corporation (HK), National Ageing Research Institute (AU), The London College (GB), University College London (GB), University of Gothenburg (SE)
Industry, innovation and infrastructure
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Transforming dementia diagnostics and care: developing a novel, cost‐effective technology to facilitate widespread and cost‐effective clinical implementation of neurofilament light and other biomarkers — Christa Dang, Dhamidhu Eratne, et al. · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS